Pradaxa and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pradaxa (dabigatran etexilate mesylate) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include cough among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Pradaxa and Solu-cortef. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

On Jul, 28, 2026

12 people who take Pradaxa and Solu-cortef together, and have interactions are studied.

Pradaxa and Solu-cortef drug interactions.

What are the common drug interactions of Pradaxa and Solu-Cortef, by gender? *:

female:

Cough
Rash
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Burning sensation
Cold sweat
Discomfort
Ear infection
Fatigue (feeling of tiredness)
Feeding disorder (when children refuse to eat certain food groups)
Fungal infection

male:

Cellulitis (infection under the skin)
Sepsis (a severe blood infection that can lead to organ failure and death)
Burning sensation
Chest discomfort
Dyspnoea (difficult or laboured respiration)
Eye swelling
Flushing (the warm, red condition of human skin)
Infusion related reaction
Pruritus (severe itching of the skin)
Throat tightness

What are the common drug interactions of Pradaxa and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Oesophageal candidiasis (fungal infection of oesophagus)

30-39:

n/a

40-49:

n/a

50-59:

Cellulitis (infection under the skin)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Cushingoid (obesity and weakening of the muscles)
Oedema (fluid collection in tissue)
Burning sensation
Cardiac arrest
Chest discomfort
Cough
Dyspnoea (difficult or laboured respiration)
Eye swelling
Fluid retention (an abnormal accumulation of fluid in the blood)
Flushing (the warm, red condition of human skin)

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 33.33%
Weakness: 3 people, 25.00%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 25.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 25.00%
Cellulitis (infection under the skin): 3 people, 25.00%
Constipation: 3 people, 25.00%
Depression: 3 people, 25.00%
Diarrhea: 3 people, 25.00%
Enlarged Prostate: 3 people, 25.00%
Groin Infection (infection in groin): 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pradaxa and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously